Overview

Ecopipam Treatment of Tourette Syndrome

Status:
Completed

Trial end date:
2013-07-01

Target enrollment:

Participant gender:

Summary

Tourette's Syndrome is a neurological disease characterized by verbal and motor tics. The currently available drug treatments are considered to be inadequate. This clinical trial is designed to test if ecopipam is effective for the treatment of Tourette's Syndrome in adults.

Phase:

Phase 1/Phase 2

Details

Lead Sponsor:

Psyadon Pharma

Treatments:

Ecopipam